跳至主要内容
临床试验/NCT03824860
NCT03824860已完成不适用

Yoga for Painful Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized-Controlled Study

Dana-Farber Cancer Institute2 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2019年8月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
47
试验地点
2
主要终点
Frequency of yoga practice by participants

研究概览

简要总结

This research study will examine the feasibility of conducting an eight-week yoga intervention for individuals with chronic painful chemotherapy-induced peripheral neuropathy.

详细描述

This research study will examine the feasibility of conducting an eight-week yoga intervention for individuals with chronic painful chemotherapy-induced peripheral neuropathy. The investigators will also explore participants' perceptions of acceptability and satisfaction with the yoga intervention. Lastly, the investigators will examine changes in chemotherapy-induced peripheral neuropathy severity, physical function, sleep-related impairment, fatigue, anxiety, depression, and pain following the eight-week yoga intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 years of age,
  • self-report ≥ 4/10 worst chemotherapy-induced peripheral neuropathy pain over the past week,
  • at least three months post neurotoxic chemotherapy completion
  • signed informed consent,
  • willingness to participate in all study activities
  • speak/read English

排除标准

  • prognosis of less than three months,
  • documented peripheral neuropathy due to other causes (e.g., diabetes),
  • planned receipt of neurotoxic chemotherapy during the study period,
  • practice yoga >45 minutes per week over the past six months,
  • diagnosis or documented recent history of significant psychiatric comorbidity (i.e., psychosis, suicidal ideation, or substance abuse)
  • clinician deems that the patient is physically/functionally unable to participate in a yoga program

结局指标

主要结局

Frequency of yoga practice by participants

时间窗: From enrollment to end of treatment at 8 weeks.

Feasibility of participant adherence to the yoga intervention

Number of participants recruited to participate in the study

时间窗: From enrollment to end of treatment at 8 weeks.

Feasibility of participant recruitment to the study

Frequency of outcome assessments completed by participants.

时间窗: From enrollment to end of treatment at 8 weeks.

Feasibility of participant adherence to outcome assessments

次要结局

  • Fatigue assessed by Change in Patient Reported Outcomes Measurement Information System (PROMIS) Fatigue(At the time of enrollment and at the end of treatment, 8 weeks after enrollment)
  • Physical Function(At the time of enrollment and at the end of treatment, at 8 weeks.)
  • Anxiety assessed by the "Change in Patient Reported Outcomes Measurement Information System (PROMIS) Anxiety"(At the time of enrollment and at the end of treatment, 8 weeks after enrollment)
  • Acceptability and Satisfaction with Participation in Yoga Intervention(At the end of treatment, 8 weeks after enrollment)
  • Pain Interference(At the time of enrollment and at the end of treatment, 8 weeks after enrollment)
  • Worst Chemotherapy-Induced Peripheral Neuropathy Pain Intensity(At the time of enrollment and at the end of treatment, 8 weeks after enrollment)
  • Chemotherapy-Induced Peripheral Neuropathy Severity(From enrollment to end of treatment at 8 weeks.At the time of enrollment and at the end of treatment, 8 weeks after enrollment)
  • Sleep-Related Impairment(At the time of enrollment and at the end of treatment, 8 weeks after enrollment)
  • Depression assessed by Change in Patient Reported Outcomes Measurement Information System (PROMIS) Depression(At the time of enrollment and at the end of treatment, 8 weeks after enrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert Knoerl, PhD, RN

Principal Investigator

Dana-Farber Cancer Institute

研究点 (2)

Loading locations...

相似试验